emerging glp-1 gip obesity treatments 2025 Nutritional priorities to support therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Medicine Association, and the Obesity Society Beyond GLP-1: the next wave

Why GLP-1 causes hair loss and how to stop it Supplements for perimenopause and menopause What about experimental microneedle GLP-1 patches

Document that your intervention is part of comprehensive care, not isolated cosmetic prescribing

(The FDA has received more than 700 adverse event reports tied to compounded GLP-1s, but its not clear if the events were caused by the drugs.) The companies also see compounders as a threat to their obesity drug sales, which are estimated to balloon to $100 billion a year by 2030

Food and Drug Administration (FDA) granted approval to Novo Nordisk's oral version of Wegovy

The act established a critical definition for pharmacy compounding: peptides are amino acid chains with fewer than 40 amino acids